GSA CAPITAL PARTNERS LLP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in LRMR

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$152,737

-$236,031 QoQ

Shares Held

50,078

-50.9% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#76

of 163 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. LRMR ranks #134 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$152,737	50,078	-50.9%	Shares	Sole	2026-08-06
2025-12-31	$388,768	102,039	+25.3%	Shares	Sole	2026-02-06
2025-09-30	$262,941	81,406	-18.5%	Shares	Sole	2025-11-07
2025-06-30	$288,774	99,922	-32.7%	Shares	Sole	2025-07-22
2024-12-31	$574,822	148,533	+38.3%	Shares	Sole	2025-02-07
2024-09-30	$703,522	107,408	+108.9%	Shares	Sole	2024-11-05
2024-06-30	$372,824	51,424	+76.9%	Shares	Sole	2024-08-15
2024-03-31	$220,580	29,062	+15.2%	Shares	Sole	2024-05-03
2023-12-31	$114,805	25,232	-71.7%	Shares	Sole	2024-02-16
2023-09-30	$352,391	89,213	+59.8%	Shares	Sole	2023-11-15
2023-06-30	$174,719	55,821	+417.2%	Shares	Sole	2023-08-14
2023-03-31	$48,887	10,792	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.